HealthResJ, health, medicine, nursing, research

Administration of ascorbic acid in the treatment of septic shock

Published: Jul 15, 2021
Sepsis septic shock ascorbic acid
Angeliki Stamouli
Christina Marvaki
George Vasilopoulos
Theodoros Kapadochos

Introduction: Septic shock is a common condition encountered in the intensive care unit. Sepsis is the leading cause of death with mortality ranging from 35-50%. Several factors are involved in the increasing incidence of sepsis including age, immunosuppression and antibiotic resistance. Gram+ or Gram- infections are considered leading causes of sepsis. Septic shock prognosis is significantly affected by early treatment. The hospitalization of the patient in the intensive care unit is particularly important as it is essential to support vital functions due to the complications of the shock.

Aim: To investigate the action of ascorbic acid in the treatment of septic shock and the benefits of its administration. 

Method-Material: Randomized trials were searched in CENTRAL, EMBASE and PubMed databases. The total number of studies included was 6. The Cochrane Risk of Bias Tool Review Manager Revman 5.3 was used to control the studies. Τhe criteria for the inclusion of patients were: age more specifically over 18 years old, patients accepted to intensive care unit with septic shock, patients with septic shock who received ascorbic acid randomized studies and cohort studies and articles in English with a time limit from 2008 to the first semester of 2020.

Results:  The results of the studies showed that patients with septicemia and septic shock have shown beneficial effects of ascorbic acid alone or in combination with corticosteroids and thiamine in the prevention of progressive organ dysfunction and in the reduction in mortality and severity of severe sepsis. Also, there was a reduced inflammatory response observed in septic shock and attenuated levels of circulatory injury biomarker.

Conclusions: Ascorbic acid has beneficial properties in septic shock and various studies have highlighted the importance of the combination of ascorbic acid and other vitamins and trace elements.

Article Details
  • Section
  • Systemic Review
Download data is not yet available.
Baltopoulos G, Grigorakos L, Karantzas S, Filntisis G, Boutzouka E, Miriantheas P. 4th Intensive Therapy Seminar Circulatory Shock, Shock, [Internet] 2001,Chapter D, Septic Shock pg 309-311,355-360 Available from: [In Greek]
Perera P, Mailhot T, Riley D, Mandavia D. The RUSH exam: Rapid Ultrasound in SHock in the evaluation of the critically lll. Emerg Med Clin North Am 2010;28(1):29-56, vii.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vin-cent JL, Moreno R; Surviving Sepsis Campaign Guide-lines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41(2):580-637.
Spink WW. Infectious Diseases: Prevention and Treat-ment in the Nineteenth and Twentieth Centuries. Min-nesota editions: University Of Minnesota Press, 1979,p 483–484.
Englard S, Seifter S. The biochemical functions of ascorbic acid. Annu Rev Nutr 1986;6:365-406.
Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recom-mended enteral and parenteral intakes. Crit Care 2017;21(1):300.
Fowler AA 3rd, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, Larus TL, Martin E, Brophy DF, Gupta S; Medical Respiratory Intensive Care Unit Nursing, Fisher BJ, Natarajan R. Phase I safe-ty trial of intravenous ascorbic acid in patients with se-vere sepsis. J Transl Med 2014;12:32.
Marik PE, Khangoora V, Rivera R, Hooper MH, Ca-travas J. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest 2017;151(6):1229-1238.
Natarajan R, Fisher B. J, Syed AA, Fowler AA, Impact of Intravenous Ascorbic Acid Infusion on Novel Bi-omarkers in Patients with Severe Sepsis. J Clin Med 2019;8(4):478.
Sadaka F, Grady J, Organti N, et al. Ascorbic Acid, Thi-amine, and Steroids in Septic Shock: Propensity Matched Analysis. J Intensive Care Med 2020;35(11):1302-1306.
Shin TG, Kim YJ, Ryoo SM, Hwang SY, Jo IJ, Chung SP, Choi SH, Suh GJ, Kim WY. Early Vitamin C and Thia-mine Administration to Patients with Septic Shock in Emergency Departments: Propensity Score-Based Analysis of a Before-and-After Cohort Study. J Clin Med 2019;8(1):102.
Most read articles by the same author(s)